Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life (Q43917659)
Jump to navigation
Jump to search
scientific article published in February 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life |
scientific article published in February 2002 |
Statements
1 reference
Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life (English)
1 reference
P Albers
1 reference
R Siener
1 reference
M Härtlein
1 reference
M Fallahi
1 reference
D Haeutle
1 reference
F G E Perabo
1 reference
G Steiner
1 reference
J Blatter
1 reference
S C Müller
1 reference
German TCC Study Group of the German Association of Urologic Oncology
1 reference
1 February 2002
1 reference
Identifiers
1 reference